Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-11-25, Stock:ABBV, The news for the past five days is as follows:
2019-11-18: NEWS1: AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes.
2019-11-19: NEWS1: Drug Legislation Likely to Dry Up Biotech Funding.NEWS2: Pfizer Gets FDA Approval for Biosimilar of AbbVie's Humira.NEWS3: AbbVie- On the Cutting Edge.
2019-11-20: NEWS1: Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - November 20, 2019.NEWS2: Myovant Up on Successful Completion of Prostate Cancer Study.NEWS3: Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology.NEWS4: 5 Corporate Giants That Popped After Latest Earnings Release.
2019-11-21: NEWS1: AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annual Meeting.NEWS2: Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting TriTAC®, and Expand Existing Discovery Collaboration.
2019-11-22: NEWS1: Pharma Stock Roundup: FDA Nod to NVS' & AZN's Drugs, BMY-CELG Merger Closes.NEWS2: AstraZeneca shares rise on early U.S. approval for leukemia drug.

Answer: Rise